cloudfront

Report Detail



Pharma & HealthcareGlobal Doxorubicin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

  • RnM2414558
  • |
  • 14 September, 2018
  • |
  • Global
  • |
  • 124 pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

Global Doxorubicin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023

Table of Contents

    1 Market Overview

    • 1.1 Doxorubicin Introduction
    • 1.2 Market Analysis by Type
    • 1.2.1 Lyophilized Powder
  • 1.2.2 Doxorubicin Injection
  • 1.3 Market Analysis by Applications
  • 1.3.1 Ovarian
  • 1.3.2 Multiple Myeloma
  • 1.3.3 Kaposi Sarcoma
  • 1.3.4 Leukemia
  • 1.3.5 Bone Sarcoma
  • 1.3.6 Breast
  • 1.3.7 Gastric
  • 1.3.8 Liver
  • 1.3.9 Kidney
  • 1.4 Market Analysis by Regions
  • 1.4.1 North America (United States, Canada and Mexico)
  • 1.4.1.1 United States Market States and Outlook (2013-2023)
  • 1.4.1.2 Canada Market States and Outlook (2013-2023)
  • 1.4.1.3 Mexico Market States and Outlook (2013-2023)
  • 1.4.2 Europe (Germany, France, UK, Russia and Italy)
  • 1.4.2.1 Germany Market States and Outlook (2013-2023)
  • 1.4.2.2 France Market States and Outlook (2013-2023)
  • 1.4.2.3 UK Market States and Outlook (2013-2023)
  • 1.4.2.4 Russia Market States and Outlook (2013-2023)
  • 1.4.2.5 Italy Market States and Outlook (2013-2023)
  • 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
  • 1.4.3.1 China Market States and Outlook (2013-2023)
  • 1.4.3.2 Japan Market States and Outlook (2013-2023)
  • 1.4.3.3 Korea Market States and Outlook (2013-2023)
  • 1.4.3.4 India Market States and Outlook (2013-2023)
  • 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
  • 1.4.4 South America, Middle East and Africa
  • 1.4.4.1 Brazil Market States and Outlook (2013-2023)
  • 1.4.4.2 Egypt Market States and Outlook (2013-2023)
  • 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
  • 1.4.4.4 South Africa Market States and Outlook (2013-2023)
  • 1.4.4.5 Nigeria Market States and Outlook (2013-2023)
  • 1.5 Market Dynamics
  • 1.5.1 Market Opportunities
  • 1.5.2 Market Risk
  • 1.5.3 Market Driving Force
  • 2 Manufacturers Profiles

    • 2.1 Sun Pharmaceuticals
    • 2.1.1 Business Overview
  • 2.1.2 Doxorubicin Type and Applications
  • 2.1.2.1 Product A
  • 2.1.2.2 Product B
  • 2.1.3 Sun Pharmaceuticals Doxorubicin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.2 Pfizer
  • 2.2.1 Business Overview
  • 2.2.2 Doxorubicin Type and Applications
  • 2.2.2.1 Product A
  • 2.2.2.2 Product B
  • 2.2.3 Pfizer Doxorubicin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.3 Cipla
  • 2.3.1 Business Overview
  • 2.3.2 Doxorubicin Type and Applications
  • 2.3.2.1 Product A
  • 2.3.2.2 Product B
  • 2.3.3 Cipla Doxorubicin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.4 Cadila Pharmaceuticals
  • 2.4.1 Business Overview
  • 2.4.2 Doxorubicin Type and Applications
  • 2.4.2.1 Product A
  • 2.4.2.2 Product B
  • 2.4.3 Cadila Pharmaceuticals Doxorubicin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 2.5 SRS Pharmaceuticals
  • 2.5.1 Business Overview
  • 2.5.2 Doxorubicin Type and Applications
  • 2.5.2.1 Product A
  • 2.5.2.2 Product B
  • 2.5.3 SRS Pharmaceuticals Doxorubicin Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
  • 3 Global Doxorubicin Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

    • 3.1 Global Doxorubicin Sales and Market Share by Manufacturer (2016-2017)
    • 3.2 Global Doxorubicin Revenue and Market Share by Manufacturer (2016-2017)
    • 3.3 Market Concentration Rate
    • 3.3.1 Top 3 Doxorubicin Manufacturer Market Share in 2017
  • 3.3.2 Top 6 Doxorubicin Manufacturer Market Share in 2017
  • 3.4 Market Competition Trend
  • 4 Global Doxorubicin Market Analysis by Regions

    • 4.1 Global Doxorubicin Sales, Revenue and Market Share by Regions
    • 4.1.1 Global Doxorubicin Sales and Market Share by Regions (2013-2018)
  • 4.1.2 Global Doxorubicin Revenue and Market Share by Regions (2013-2018)
  • 4.2 North America Doxorubicin Sales and Growth Rate (2013-2018)
  • 4.3 Europe Doxorubicin Sales and Growth Rate (2013-2018)
  • 4.4 Asia-Pacific Doxorubicin Sales and Growth Rate (2013-2018)
  • 4.5 South America Doxorubicin Sales and Growth Rate (2013-2018)
  • 4.6 Middle East and Africa Doxorubicin Sales and Growth Rate (2013-2018)
  • 5 North America Doxorubicin by Countries

    • 5.1 North America Doxorubicin Sales, Revenue and Market Share by Countries
    • 5.1.1 North America Doxorubicin Sales and Market Share by Countries (2013-2018)
  • 5.1.2 North America Doxorubicin Revenue and Market Share by Countries (2013-2018)
  • 5.2 United States Doxorubicin Sales and Growth Rate (2013-2018)
  • 5.3 Canada Doxorubicin Sales and Growth Rate (2013-2018)
  • 5.4 Mexico Doxorubicin Sales and Growth Rate (2013-2018)
  • 6 Europe Doxorubicin by Countries

    • 6.1 Europe Doxorubicin Sales, Revenue and Market Share by Countries
    • 6.1.1 Europe Doxorubicin Sales and Market Share by Countries (2013-2018)
  • 6.1.2 Europe Doxorubicin Revenue and Market Share by Countries (2013-2018)
  • 6.2 Germany Doxorubicin Sales and Growth Rate (2013-2018)
  • 6.3 UK Doxorubicin Sales and Growth Rate (2013-2018)
  • 6.4 France Doxorubicin Sales and Growth Rate (2013-2018)
  • 6.5 Russia Doxorubicin Sales and Growth Rate (2013-2018)
  • 6.6 Italy Doxorubicin Sales and Growth Rate (2013-2018)
  • 7 Asia-Pacific Doxorubicin by Countries

    • 7.1 Asia-Pacific Doxorubicin Sales, Revenue and Market Share by Countries
    • 7.1.1 Asia-Pacific Doxorubicin Sales and Market Share by Countries (2013-2018)
  • 7.1.2 Asia-Pacific Doxorubicin Revenue and Market Share by Countries (2013-2018)
  • 7.2 China Doxorubicin Sales and Growth Rate (2013-2018)
  • 7.3 Japan Doxorubicin Sales and Growth Rate (2013-2018)
  • 7.4 Korea Doxorubicin Sales and Growth Rate (2013-2018)
  • 7.5 India Doxorubicin Sales and Growth Rate (2013-2018)
  • 7.6 Southeast Asia Doxorubicin Sales and Growth Rate (2013-2018)
  • 8 South America Doxorubicin by Countries

    • 8.1 South America Doxorubicin Sales, Revenue and Market Share by Countries
    • 8.1.1 South America Doxorubicin Sales and Market Share by Countries (2013-2018)
  • 8.1.2 South America Doxorubicin Revenue and Market Share by Countries (2013-2018)
  • 8.2 Brazil Doxorubicin Sales and Growth Rate (2013-2018)
  • 8.3 Argentina Doxorubicin Sales and Growth Rate (2013-2018)
  • 8.4 Colombia Doxorubicin Sales and Growth Rate (2013-2018)
  • 9 Middle East and Africa Doxorubicin by Countries

    • 9.1 Middle East and Africa Doxorubicin Sales, Revenue and Market Share by Countries
    • 9.1.1 Middle East and Africa Doxorubicin Sales and Market Share by Countries (2013-2018)
  • 9.1.2 Middle East and Africa Doxorubicin Revenue and Market Share by Countries (2013-2018)
  • 9.2 Saudi Arabia Doxorubicin Sales and Growth Rate (2013-2018)
  • 9.3 UAE Doxorubicin Sales and Growth Rate (2013-2018)
  • 9.4 Egypt Doxorubicin Sales and Growth Rate (2013-2018)
  • 9.5 Nigeria Doxorubicin Sales and Growth Rate (2013-2018)
  • 9.6 South Africa Doxorubicin Sales and Growth Rate (2013-2018)
  • 10 Global Doxorubicin Market Segment by Type

    • 10.1 Global Doxorubicin Sales, Revenue and Market Share by Type (2013-2018)
    • 10.1.1 Global Doxorubicin Sales and Market Share by Type (2013-2018)
  • 10.1.2 Global Doxorubicin Revenue and Market Share by Type (2013-2018)
  • 10.2 Lyophilized Powder Sales Growth and Price
  • 10.2.1 Global Lyophilized Powder Sales Growth (2013-2018)
  • 10.2.2 Global Lyophilized Powder Price (2013-2018)
  • 10.3 Doxorubicin Injection Sales Growth and Price
  • 10.3.1 Global Doxorubicin Injection Sales Growth (2013-2018)
  • 10.3.2 Global Doxorubicin Injection Price (2013-2018)
  • 11 Global Doxorubicin Market Segment by Application

    • 11.1 Global Doxorubicin Sales Market Share by Application (2013-2018)
    • 11.2 Ovarian Sales Growth (2013-2018)
    • 11.3 Multiple Myeloma Sales Growth (2013-2018)
    • 11.4 Kaposi Sarcoma Sales Growth (2013-2018)
    • 11.5 Leukemia Sales Growth (2013-2018)
    • 11.6 Bone Sarcoma Sales Growth (2013-2018)
    • 11.7 Breast Sales Growth (2013-2018)
    • 11.8 Gastric Sales Growth (2013-2018)
    • 11.9 Liver Sales Growth (2013-2018)
    • 11.10 Kidney Sales Growth (2013-2018)

    12 Doxorubicin Market Forecast (2018-2023)

    • 12.1 Global Doxorubicin Sales, Revenue and Growth Rate (2018-2023)
    • 12.2 Doxorubicin Market Forecast by Regions (2018-2023)
    • 12.2.1 North America Doxorubicin Market Forecast (2018-2023)
  • 12.2.2 Europe Doxorubicin Market Forecast (2018-2023)
  • 12.2.3 Asia-Pacific Doxorubicin Market Forecast (2018-2023)
  • 12.2.4 South America Doxorubicin Market Forecast (2018-2023)
  • 12.2.5 Middle East and Africa Doxorubicin Market Forecast (2018-2023)
  • 12.3 Doxorubicin Market Forecast by Type (2018-2023)
  • 12.3.1 Global Doxorubicin Sales Forecast by Type (2018-2023)
  • 12.3.2 Global Doxorubicin Market Share Forecast by Type (2018-2023)
  • 12.4 Doxorubicin Market Forecast by Application (2018-2023)
  • 12.4.1 Global Doxorubicin Sales Forecast by Application (2018-2023)
  • 12.4.2 Global Doxorubicin Market Share Forecast by Application (2018-2023)
  • 13 Sales Channel, Distributors, Traders and Dealers

    • 13.1 Sales Channel
    • 13.1.1 Direct Marketing
  • 13.1.2 Indirect Marketing
  • 13.1.3 Marketing Channel Future Trend
  • 13.2 Distributors, Traders and Dealers
  • 14 Research Findings and Conclusion

      15 Appendix

      • 15.1 Methodology

      Doxorubicin is a kind of antitumor antibiotics, can inhibit the synthesis of RNA and DNA, RNA in the strongest inhibitory effect.

      Scope of the Report:

      This report focuses on the Doxorubicin in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

      Doxorubicin has an effect on a wide variety of tumor, belongs to the cycle non-specific drug, have all sorts of growth cycle of tumor cells to kill.it's given by injection into a vein.

      The worldwide market for Doxorubicin is expected to grow at a CAGR of roughly 5.1% over the next five years, will reach 1230 million US$ in 2023, from 910 million US$ in 2017, according to a new GIR (Global Info Research) study.

      Market Segment by Manufacturers, this report covers

      Sun Pharmaceuticals

      Pfizer

      Cipla

      Cadila Pharmaceuticals

      SRS Pharmaceuticals

      Market Segment by Regions, regional analysis covers

      North America (United States, Canada and Mexico)

      Europe (Germany, France, UK, Russia and Italy)

      Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

      South America (Brazil, Argentina, Colombia etc.)

      Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

      Market Segment by Type, covers

      Lyophilized Powder

      Doxorubicin Injection

      Market Segment by Applications, can be divided into

      Ovarian

      Multiple Myeloma

      Kaposi Sarcoma

      Leukemia

      Bone Sarcoma

      Breast

      Gastric

      Liver

      Kidney

      There are 15 Chapters to deeply display the global Doxorubicin market.

      Chapter 1, to describe Doxorubicin Introduction, product scope, market overview, market opportunities, market risk, market driving force;

      Chapter 2, to analyze the top manufacturers of Doxorubicin, with sales, revenue, and price of Doxorubicin, in 2016 and 2017;

      Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

      Chapter 4, to show the global market by regions, with sales, revenue and market share of Doxorubicin, for each region, from 2013 to 2018;

      Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

      Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

      Chapter 12, Doxorubicin market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

      Chapter 13, 14 and 15, to describe Doxorubicin sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source




      Summary:
      Get latest Market Research Reports on Doxorubicin . Industry analysis & Market Report on Doxorubicin is a syndicated market report, published as Global Doxorubicin Market 2018 by Manufacturers, Regions, Type and Application, Forecast to 2023. It is complete Research Study and Industry Analysis of Doxorubicin market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.


      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,480.00
      $5,220.00
      $6,960.00
      2,336.82
      3,505.23
      4,673.64
      3,202.30
      4,803.44
      6,404.59
      421,567.20
      632,350.80
      843,134.40
      230,770.63
      346,155.95
      461,541.26
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report